Jacob White

BD (Becton, Dickinson and Company), a medical technology company, has announced a partnership with the US government under which the company has agreed to invest $19 billion in the US…

Bayer has announced plans to invest $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio.   The modular campus is designed to combine drug-substance and drug-product manufacturing, use…

AstraZeneca has announced the opening of a new $1-billion global strategic research and development (R&D) center, in Kendall Square, Cambridge, Massachusetts. The center is part of the company’s previously announced…

Biohub, a nonprofit research institute combining AI and biology, the US Department of Energy (DoE), the National Institutes of Health (NIH), and new funding partners, Google DeepMind (an AI research…

The latest from CDMOs, CMOs, and suppliers featuring BASF, Evonik, Flamma, Curia, Hovione, Catalent,  Repligen, Piramal Pharma Solutions, Agilent Technologies, Thermo Fisher Scientific, Evotec, Sterling Pharma Solutions, Ofichem, Ritedose Corporation,…

A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring Novo, Merck & Co., Shionogi, Viatris, Teva Pharmaceuticals, Roche and CSL. Highlights below.   For the latest news roundup…

The latest from small and Emerging Pharma companies featuring NorthStar Medical Technologies, Matchpoint Therapeutics, TRex Bio, Retension Pharmaceuticals, and Lycia Therapeutics.  For news on the large and mid-sized bio/pharmaceutical companies,…

Roche’s Genentech has broken ground on a $750-million, 211,000-square-foot expansion of its manufacturing facility in Hillsboro, Oregon, to add device fill–finish capabilities, including the manufacturing of combination products. The investment…

AstraZeneca has agreed to take a $2-billion equity stake in Summit Therapeutics, a Miami-based bio/pharmaceutical company, and the companies have formed a clinical collaboration to evaluate Summit’s lead drug candidate,…

Sanofi has expanded its antibody collaboration with Regeneron Pharmaceuticals, a Tarrytown, New York-based bio/pharmaceutical company, to add four new drug candidates in an $8-billion deal ($1 billion upfront and $7…